Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Cancer

Research Field Genetics

Kallikrein Dream

| Roisin McGuigan

Eleftherios P. Diamandis, Hold ’em for Life Chair in Prostate Cancer Biomarkers, University of Toronto.

Research Field Cancer

Leidenfrost Nanochemistry

| James Strachan

Scientists fabricate anticancer nanoparticles by recreating deep sea volcano chemistry.

Tools & Techniques Cancer

Rush at Your Peril

| Eleftherios P. Diamandis

False discoveries have plagued biomarker research for years: don't trust everything you read.

Tools & Techniques Cancer

CEA: Overlooked and Underused

| Roisin McGuigan

Could an existing blood test improve treatment choices – and outcomes – for some colon cancer patients?

Tools & Techniques Cancer

Getting Smart with Clinical Trials

| Joy Yucaitis

Liquid biopsy technology could help boost clinical trial success.

Research Field Omics

Embracing the Proteogenomic Toolkit

| Andreas Hühmer

To win the war on cancer, we need to put proteomics on an equal footing with genomics.

Tools & Techniques Cancer

The Rise of ctDNA, Part Two

| Michael Schubert

Circulating tumor DNA profiling can yield new insights into early-stage lung cancer evolution.

Tools & Techniques Cancer

The Rise of ctDNA, Part One

| Roisin McGuigan

New ctDNA assays could make more metastatic melanoma cases detectable.

Tools & Techniques Cancer

Cracking Cancer’s Code

| Roisin McGuigan

Sitting Down With George Calin, Professor, The University of Texas MD Anderson Cancer Center, USA.

Tools & Techniques Cancer

A Winning Combination?

| Roisin McGuigan

Engineering more effective antibody-drug conjugates.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register